Manolete S. Moscoso

Manolete S. Moscoso

Auto-generated profile, based on publicly available information

Manolete S. Moscoso

University of South Florida, Tampa, Florida

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2009 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
CLCecile A. Lengacher
Cecile A. Lengacher
VJVersie Johnson‐Mallard
Versie Johnson‐Mallard
JPJanice Post‐White
Janice Post‐White
MMManolete S. Moscoso
Manolete S. Moscoso
PJPaul B. Jacobsen
Paul B. Jacobsen
KKKevin Kip
Kevin Kip
Objectives: Considerable morbidity persists among survivors of breast cancer (BC) including high levels of psychological stress, anxiety, depression, fear of recurrence, and physical symptoms including pain, fatigue, and sleep disturbances, and impaired quality of life. Effective interventions are needed during this difficult transitional period.Methods: We conducted a randomized controlled trial of 84 female BC survivors (Stages 0–III) recruited from the H. Lee Moffitt Cancer and Research Institute. All subjects were within 18 months of treatment completion with surgery and adjuvant radiation and/or chemotherapy. Subjects were randomly assigned to a 6‐week Mindfulness‐Based Stress Reduction (MBSR) program designed to self‐regulate arousal to stressful circumstances or symptoms (n=41) or to usual care (n=43). Outcome measures compared at 6 weeks by random assignment included validated measures of psychological status (depression, anxiety, perceived stress, fear of recurrence, optimism, social support) and psychological and physical subscales of quality of life (SF‐36).Results: Compared with usual care, subjects assigned to MBSR(BC) had significantly lower (two‐sided p<0.05) adjusted mean levels of depression (6.3 vs 9.6), anxiety (28.3 vs 33.0), and fear of recurrence (9.3 vs 11.6) at 6 weeks, along with higher energy (53.5 vs 49.2), physical functioning (50.1 vs 47.0), and physical role functioning (49.1 vs 42.8). In stratified analyses, subjects more compliant with MBSR tended to experience greater improvements in measures of energy and physical functioning.Conclusions: Among BC survivors within 18 months of treatment completion, a 6‐week MBSR(BC) program resulted in significant improvements in psychological status and quality of life compared with usual care. Copyright © 2009 John Wiley & Sons, Ltd

20 August 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CLCecile A. Lengacher
Cecile A. Lengacher
RRRichard R. Reich
Richard R. Reich
CPCarly L. Paterson
Carly L. Paterson
SRSophia Ramesar
Sophia Ramesar
JPJong Y. Park
Jong Y. Park
KKKevin E. Kip
Kevin E. Kip
Purpose: The purpose of this randomized trial was to evaluate the efficacy of the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR[BC]) program in improving psychological and physical symptoms and quality of life among breast cancer survivors (BCSs) who completed treatment. Outcomes were assessed immediately after 6 weeks of MBSR(BC) training and 6 weeks later to test efficacy over an extended timeframe. Patients and Methods: A total of 322 BCSs were randomly assigned to either a 6-week MBSR(BC) program (n = 155) or a usual care group (n = 167). Psychological (depression, anxiety, stress, and fear of recurrence) and physical symptoms (fatigue and pain) and quality of life (as related to health) were assessed at baseline and at 6 and 12 weeks. Linear mixed models were used to assess MBSR(BC) effects over time, and participant characteristics at baseline were also tested as moderators of MBSR(BC) effects. Results: Results demonstrated extended improvement for the MBSR(BC) group compared with usual care in both psychological symptoms of anxiety, fear of recurrence overall, and fear of recurrence problems and physical symptoms of fatigue severity and fatigue interference (P < .01). Overall effect sizes were largest for fear of recurrence problems (d = 0.35) and fatigue severity (d = 0.27). Moderation effects showed BCSs with the highest levels of stress at baseline experienced the greatest benefit from MBSR(BC). Conclusion: The MBSR(BC) program significantly improved a broad range of symptoms among BCSs up to 6 weeks after MBSR(BC) training, with generally small to moderate overall effect sizes.

1 January 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
RRRichard R. Reich
Richard R. Reich
CLCecile A. Lengacher
Cecile A. Lengacher
CACarissa B. Alinat
Carissa B. Alinat
KKKevin E. Kip
Kevin E. Kip
CPCarly Paterson
Carly Paterson
JPJong Park
Jong Park

20 April 2011 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
CLCecile A. Lengacher
Cecile A. Lengacher
RRRichard R. Reich
Richard R. Reich
JPJanice Post-White
Janice Post-White
MMManolete Moscoso
Manolete Moscoso
MSMelissa M. Shelton
Melissa M. Shelton
PBPinky Budhrani
Pinky Budhrani

21 March 2012 in Journal of Holistic Nursing
Verified
Journal Article
Closed access
CLCecile A. Lengacher
Cecile A. Lengacher
KKKevin E. Kip
Kevin E. Kip
MBMichelle Barta
Michelle Barta
JPJanice Post-White
Janice Post-White
PJPaul B. Jacobsen
Paul B. Jacobsen
MSMelissa Molinari Shelton
Melissa Molinari Shelton
Purpose: To investigate whether a mindfulness-based stress reduction program for cancer (MBSR-C) improved psychological and physical symptoms, quality of life (QOL), and stress markers among advanced-stage cancer patients and caregivers. Design: A pilot within-subject design was used. Method: Patients previously diagnosed with advanced-stage breast, colon, lung, or prostate cancer and on treatment were recruited from the Moffitt Cancer Center and Research Institute. Twenty-six patient–caregiver dyads completed a modified 6-week, self-study MBSR-C program based on the Kabat–Zinn model. Psychological and physical symptoms and QOL were compared pre– and post–MBSR-C sessions. Salivary cortisol and interleukin-6 were assessed pre– and post–MBSR-C session at 1, 3, and 6 weeks. Findings: Following the 6-week MBSR program, patients showed improvements in stress and anxiety (p < .05); caregivers’ psychological and QOL also improved but were not statistically significant. Both patients and caregivers had decreases in cortisol at Weeks 1 and 3 (p < .05) but not at Week 6. Similar to cortisol levels at Week 6, salivary interleukin-6 levels were lower overall (before/after an MBSR-C session), compared with Week 1 for patients and caregivers. Conclusions: MBSR-C may be a beneficial intervention for reducing stress, anxiety, cortisol levels, and symptoms in advanced-stage cancer patients and may also benefit caregivers.

18 June 2014 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
CLCecile A. Lengacher
Cecile A. Lengacher
RRRichard R. Reich
Richard R. Reich
CPCarly L. Paterson
Carly L. Paterson
HJHeather S. Jim
Heather S. Jim
SRSophia Ramesar
Sophia Ramesar
KKKevin E. Kip
Kevin E. Kip